ProStrakan appoints Tom Stratford as CEO
This article was originally published in Scrip
Executive Summary
ProStrakan Group, a subsidiary of Kyowa Hakko Kirin and a speciality pharmaceutical company, has appointed Dr Tom Stratford chief executive officer. Dr Stratford takes over from Peter Allen, who has been acting chief executive since September 2010 and will revert to his role as non-executive chairman. Dr Stratford most recently served as executive vice-president of business development for ProStrakan.